Millions of Medicare beneficiaries will gain access to obesity drugs for the first time starting Wednesday under CMS’ ...

If you want to talk to your health care provider about weight loss medications, Saxenda and Zepbound are two options you may ...

Zepbound (tirzepatide) is a once-a-week injectable weight-loss medication. It helps reduce your appetite by influencing two hormones: glucagon-like peptide-1 (GLP-1) and glucose-dependent ...

Insurance may cover Zepbound (tirzepatide) depending on your plan and the specific condition being treated. To determine whether your plan covers Zepbound, contact your insurance provider directly. If ...

Eligible patients may pay as low as $25 a month for their medicine INDIANAPOLIS, May 28, 2026 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced an access milestone in obesity care: all ...

Everyday Health independently vets all recommended products. If you purchase a featured product, we may be compensated. Learn why you can trust us. Everyday Health independently vets all recommended ...

Zepbound is a prescription injection used to help with weight loss and weight management as well as treat obstructive sleep apnea in adults. It’s common to have questions while taking a medication.

Medicare will start the GLP-1 Bridge program July 1. Older adults who qualify for the weight-loss drugs will pay a monthly ...

Walmart, with nearly 4,600 pharmacies nationwide, will serve as the first in-store pickup pharmacy for LillyDirect's self-pay single-dose vials Strategic collaboration marks the first time patients ...

Zepbound, which contains the active ingredient tirzepatide, has Food and Drug Administration (FDA) approval for the following: weight management in adults with obesity weight management in adults with ...